Literature DB >> 1805350

Assessment of enduring deficit and negative symptom subtypes in schizophrenia.

K T Mueser1, M S Douglas, A S Bellack, R L Morrison.   

Abstract

The clinical importance of subtypes based on enduring deficit or negative symptoms was examined in a group of schizophrenic patients who were assessed twice over a 1-year period. Subgroups of patients with high levels of enduring negative or deficit symptoms, based on the Scale for the Assessment of Negative Symptoms and the Quality of Life Scale, had a poorer prognosis and were consistently worse in social adjustment, quality of life, and thought disorder over the year than were patients with less severe negative symptoms. Subtypes based on Andreasen's negative schizophrenia classification and on enduring thought disorder were only weakly related to other symptoms and social adjustment. Social-skill deficits were weakly related to the enduring negative symptom subtype and Andreasen's negative schizophrenia. The results suggest that enduring negative and deficit symptoms may be associated with a poor outcome in schizophrenia, including more severe positive symptoms, lower levels of social adjustment, and a poorer quality of life.

Entities:  

Mesh:

Year:  1991        PMID: 1805350     DOI: 10.1093/schbul/17.4.565

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  18 in total

Review 1.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

2.  The Illness Management and Recovery program: rationale, development, and preliminary findings.

Authors:  Kim T Mueser; Piper S Meyer; David L Penn; Richard Clancy; Donna M Clancy; Michelle P Salyers
Journal:  Schizophr Bull       Date:  2006-08-09       Impact factor: 9.306

3.  Residential environment and quality of life among seriously mentally ill residents of board and care homes.

Authors:  Alvin S Mares; Alexander S Young; James F Mcguire; Robert A Rosenheck
Journal:  Community Ment Health J       Date:  2002-12

4.  Insight among people with severe mental illness, co-occurring PTSD and elevated psychotic symptoms: Correlates and relationship to treatment participation.

Authors:  Philip T Yanos; Beth Vayshenker; Pavel Pleskach; Kim T Mueser
Journal:  Compr Psychiatry       Date:  2016-04-28       Impact factor: 3.735

5.  Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness.

Authors:  Kim T Mueser; Sarah I Pratt; Stephen J Bartels; Karin Swain; Brent Forester; Corinne Cather; James Feldman
Journal:  J Consult Clin Psychol       Date:  2010-08

Review 6.  Psychosocial treatments to promote functional recovery in schizophrenia.

Authors:  Robert S Kern; Shirley M Glynn; William P Horan; Stephen R Marder
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

7.  A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness.

Authors:  Aricca D Van Citters; Sarah I Pratt; Kenneth Jue; Gail Williams; Patricia T Miller; Haiyi Xie; Stephen J Bartels
Journal:  Community Ment Health J       Date:  2009-12-10

8.  Deconstructing Negative Symptoms in Individuals at Clinical High-Risk for Psychosis: Evidence for Volitional and Diminished Emotionality Subgroups That Predict Clinical Presentation and Functional Outcome.

Authors:  Tina Gupta; Henry R Cowan; Gregory P Strauss; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-01-23       Impact factor: 9.306

9.  Longitudinal progression of negative symptoms in schizophrenia: a new look at an old problem.

Authors:  Mary E Kelley; Gretchen L Haas; Daniel P van Kammen
Journal:  Schizophr Res       Date:  2008-07-11       Impact factor: 4.939

10.  Social affiliation and negative symptoms in schizophrenia: Examining the role of behavioral skills and subjective responding.

Authors:  Jack J Blanchard; Stephanie G Park; Lauren T Catalano; Melanie E Bennett
Journal:  Schizophr Res       Date:  2015-07-31       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.